FDA 510(k)

CellDx-Tissue

N.º K: K260235 · 2026-05-12

SolicitanteDatar Cancer Genetics Private Limited

Fecha de decisión2026-05-12

Código de productoPZM

Comité asesorPA

DecisiónSubstantially Equivalent

Resumen del dispositivo

CellDx-Tissue is the device name listed in this FDA 510(k) record. The listed applicant is Datar Cancer Genetics Private Limited. It received FDA 510(k) clearance on 2026-05-12 under 510(k) number K260235. The device is classified under product code PZM. It was reviewed by the PA advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the CellDx-Tissue?

CellDx-Tissue is a medical device that received FDA 510(k) clearance on 2026-05-12. The listed applicant is Datar Cancer Genetics Private Limited. The 510(k) number is K260235.

When did CellDx-Tissue receive FDA 510(k) clearance?

CellDx-Tissue received FDA 510(k) clearance on 2026-05-12, under 510(k) number K260235.

Who is the listed applicant for CellDx-Tissue?

The FDA 510(k) record lists Datar Cancer Genetics Private Limited as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CellDx-Tissue?

The FDA product code for CellDx-Tissue is PZM.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Dispositivos relacionados (Código: PZM)

K241868xR IVDTempus AI, Inc.K250003GENESEEQPRIME NGS Tumor Profiling Assay (FFPE) (GS6005)Geneseeq Technology, Inc.K210017ACTOnco, ACTOnco IVDAct Genomics K202304NYU Langone Genome PACT (Genome Profiling of Actionable Cancer Targets)Nyu Langone Medical Center K192063PGDx elio tissue completePersonal Genome Diagnostics K190661Omics CoreNanthealth, Inc.

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.